AP2009004834A0 - Methods and compositions using immunomodulatory c ompounds for the treatment and management of spirochete and other obligate intracellular bacterial diseases - Google Patents
Methods and compositions using immunomodulatory c ompounds for the treatment and management of spirochete and other obligate intracellular bacterial diseasesInfo
- Publication number
- AP2009004834A0 AP2009004834A0 AP2009004834A AP2009004834A AP2009004834A0 AP 2009004834 A0 AP2009004834 A0 AP 2009004834A0 AP 2009004834 A AP2009004834 A AP 2009004834A AP 2009004834 A AP2009004834 A AP 2009004834A AP 2009004834 A0 AP2009004834 A0 AP 2009004834A0
- Authority
- AP
- ARIPO
- Prior art keywords
- ompounds
- spirochete
- immunomodulatory
- compositions
- management
- Prior art date
Links
- 208000035143 Bacterial infection Diseases 0.000 title 1
- 241000589970 Spirochaetales Species 0.000 title 1
- 230000002519 immonomodulatory effect Effects 0.000 title 1
- 230000003834 intracellular effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US85284606P | 2006-10-19 | 2006-10-19 | |
PCT/US2007/022388 WO2008057196A2 (en) | 2006-10-19 | 2007-10-19 | Methods and compositions using immunomodulatory compounds for the treatment and management of spirochete and other obligate intracellular bacterial diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
AP2009004834A0 true AP2009004834A0 (en) | 2009-04-30 |
Family
ID=39364972
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AP2009004834A AP2009004834A0 (en) | 2006-10-19 | 2007-10-19 | Methods and compositions using immunomodulatory c ompounds for the treatment and management of spirochete and other obligate intracellular bacterial diseases |
Country Status (8)
Country | Link |
---|---|
US (1) | US20110184025A1 (zh) |
EP (1) | EP2081561A2 (zh) |
JP (1) | JP2010506937A (zh) |
CN (1) | CN101557806A (zh) |
AP (1) | AP2009004834A0 (zh) |
CA (1) | CA2665778A1 (zh) |
MX (1) | MX2009003912A (zh) |
WO (1) | WO2008057196A2 (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8405379B1 (en) | 2008-09-18 | 2013-03-26 | Luc Montagnier | System and method for the analysis of DNA sequences in biological fluids |
US8257938B2 (en) * | 2009-02-27 | 2012-09-04 | Medical Diagnostic Laboratories, Llc | Hemolysin and its protein fragments in sero-detection of Anaplasma phagocytophilum |
RS58523B1 (sr) | 2010-02-11 | 2019-04-30 | Celgene Corp | Derivati arilmetoksi izoindolina i kombinacije koje ih obuhvataju i postupci njihove upotrebe |
US20140228455A1 (en) * | 2011-09-07 | 2014-08-14 | Alpha Biotech Ab | Determination of bacterial infections of the genus rickettsia and possibly borrelia, in patients exhibiting symptoms of disease and being blood donors |
WO2013113000A2 (en) * | 2012-01-26 | 2013-08-01 | Luc Montagnier | Detection of dna sequences as risk factors for hiv infection |
JP6469077B2 (ja) | 2013-04-02 | 2019-02-13 | セルジーン コーポレイション | 4−アミノ−2−(2,6−ジオキソ−ピペリジン3−イル)−イソインドリン−1,3−ジオンを使用する中枢神経の癌の治療及び管理のための方法及び組成物 |
EP2815749A1 (en) | 2013-06-20 | 2014-12-24 | IP Gesellschaft für Management mbH | Solid form of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione having specified X-ray diffraction pattern |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7182953B2 (en) * | 1999-12-15 | 2007-02-27 | Celgene Corporation | Methods and compositions for the prevention and treatment of atherosclerosis restenosis and related disorders |
JP4242651B2 (ja) * | 2000-11-30 | 2009-03-25 | ザ チルドレンズ メディカル センター コーポレイション | 4−アミノ−サリドマイドエナンチオマーの合成法 |
US7153867B2 (en) * | 2001-08-06 | 2006-12-26 | Celgene Corporation | Use of nitrogen substituted thalidomide analogs for the treatment of macular degenerator |
US7968569B2 (en) * | 2002-05-17 | 2011-06-28 | Celgene Corporation | Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione |
WO2003097052A2 (en) * | 2002-05-17 | 2003-11-27 | Celgene Corporation | Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
US7323479B2 (en) * | 2002-05-17 | 2008-01-29 | Celgene Corporation | Methods for treatment and management of brain cancer using 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-methylisoindoline |
US7189740B2 (en) * | 2002-10-15 | 2007-03-13 | Celgene Corporation | Methods of using 3-(4-amino-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myelodysplastic syndromes |
KR20050057672A (ko) * | 2002-10-24 | 2005-06-16 | 셀진 코포레이션 | 통증의 치료, 변형 및 관리를 위한 면역조절 화합물을포함하는 조성물 및 이의 사용 방법 |
-
2007
- 2007-10-19 AP AP2009004834A patent/AP2009004834A0/xx unknown
- 2007-10-19 EP EP07867254A patent/EP2081561A2/en not_active Withdrawn
- 2007-10-19 CA CA002665778A patent/CA2665778A1/en not_active Abandoned
- 2007-10-19 MX MX2009003912A patent/MX2009003912A/es not_active Application Discontinuation
- 2007-10-19 US US12/446,227 patent/US20110184025A1/en not_active Abandoned
- 2007-10-19 CN CNA2007800457918A patent/CN101557806A/zh active Pending
- 2007-10-19 WO PCT/US2007/022388 patent/WO2008057196A2/en active Application Filing
- 2007-10-19 JP JP2009533401A patent/JP2010506937A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2008057196A2 (en) | 2008-05-15 |
US20110184025A1 (en) | 2011-07-28 |
EP2081561A2 (en) | 2009-07-29 |
CN101557806A (zh) | 2009-10-14 |
CA2665778A1 (en) | 2008-05-15 |
JP2010506937A (ja) | 2010-03-04 |
WO2008057196A3 (en) | 2008-07-24 |
MX2009003912A (es) | 2009-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL264361A (en) | Compositions and methods for treating collagen-mediated diseases | |
IL258730A (en) | Preparations and methods for the treatment of microbial disorders | |
HK1134679A1 (zh) | 用於治療感染的組合物和方法 | |
HK1145339A1 (zh) | 用於定向整合的方法和組合物 | |
SI2182981T1 (sl) | Postopki in sestavki za zdravljenje in diagnozo fibroze | |
EP2043620A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF PARASITIC INFECTIONS | |
ZA201001810B (en) | Seed treatment compositions and methods | |
ZA201001811B (en) | Seed treatment compositions and methods | |
ZA200704784B (en) | Methods and compositions using immunomodulatory compounds for treatment and management of parasitic diseases | |
GB201108374D0 (en) | Compositions and methods for the treatment of altered synuclein function | |
EP2297341A4 (en) | METHOD AND COMPOSITIONS FOR TREATING MORBUS HUNTINGTON | |
EP2235034A4 (en) | IMMUNOMODULATORY AGENTS AND METHODS OF USE | |
EP1986587A4 (en) | FLUORIDE COMPOSITION AND METHOD FOR DENTAL MINERALIZATION | |
ZA200807398B (en) | Compositions and methods for enhancing the antioxidant status of animals | |
GB0718446D0 (en) | Compositions and methods for the treatment of infection | |
AP2009004834A0 (en) | Methods and compositions using immunomodulatory c ompounds for the treatment and management of spirochete and other obligate intracellular bacterial diseases | |
ZA200907492B (en) | Compositions for targeted imaging and therapy | |
IL198723A0 (en) | Methods and compositions for therapeutic treatment | |
EP2001400A4 (en) | ORAL FORMULATIONS OF GLYCYL-2-METHYLPROLYL-GLUTAMATE | |
EP2178490A4 (en) | FILM-CONSTITUTING DENTAL COMPOSITIONS AND CORRESPONDING METHODS | |
EP2124968A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF MUSCLE ATROPHY | |
IL195412A0 (en) | Methods and compositions using immunomodulatory compounds in combination therapy | |
SI2101574T1 (sl) | Spojine in oblike, primerne za lovljenje radikalov | |
IL208848A0 (en) | Compositions for the treatment and prevention of infections of the oral cavity | |
ZA200806668B (en) | Antiseptic compositions and methods of using same |